Evidence map›Paper›PMID 42319021›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2026

YBX1 as a developmental regulator of ventricular morphogenesis and a potential target in cardiac pathology.

Mark Viktor Füzesi, Jun Yoshioka

Abstract readComment
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mark Viktor FüzesiDepartment of Molecular, Cellular and Biomedical Sciences, City University of New York School of Medicine, New York City, United States.
Jun YoshiokaDepartment of Molecular, Cellular and Biomedical Sciences, City University of New York School of Medicine, New York City, United States.ORCID 0000-0002-7176-3414

Funding

Arrestin domain-containing protein 4 as a novel regulator of glucose metabolism in the ischemic heartR01HL166620 · NHLBI · CITY COLLEGE OF NEW YORK · PI Jun Yoshioka · 2023 to 2026
$1.6M
Hyperglycemia-induced regulatory mechanism of ER stress by arresting domain-containing protein 4 in diabetic cardiomyopathyR01HL168191 · NHLBI · CITY COLLEGE OF NEW YORK · PI Jun Yoshioka · 2024 to 2026
$1.2M
HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL166620HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL168191NHLBI NIH HHS R01 HL166620NHLBI NIH HHS R01 HL168191
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiac developmentmouse heart modelY-box binding proteins

Identifiers

PMID42319021
PMCPMC13359389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.